Dendrimers as high relaxivity MR contrast agents.

Dendrimers as high relaxivity MR contrast agents.
复制标题

DOI:
10.1002/wnan.1250
复制
发表时间:
2014-03
期刊:
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
影响因子:
--
通讯作者:
Kobayashi H
Kobayashi H
中科院分区:
其他
文献类型:
--
作者:
Longmire MR;Ogawa M;Choyke PL;Kobayashi H

文献摘要

参考文献

相似文献

树枝状大分子是一种用途广泛的大分子,作为磁共振成像(MRI)造影剂具有巨大的潜力。基于树枝状聚合物的试剂提供了明显优于低分子量钆螯合物的优势,包括由于缓慢的旋转动力学而增强的r1弛豫率,可适用于血池、肝脏、肾脏和淋巴成像的可调药代动力学,作为药物载体的能力,以及由于其固有的多价性而标记的灵活性。临床应用越来越多地被开发,特别是在淋巴成像。在这里,我们提出了一个广泛的概述树枝状聚合物为基础的MRI造影剂,注意独特的化学和物理性质,以及新兴的临床应用。
Dendrimers are versatile macromolecules with tremendous potential as magnetic resonance imaging (MRI) contrast agents. Dendrimer-based agents provide distinct advantages over low-molecular-weight gadolinium chelates, including enhanced r1 relaxivity due to slow rotational dynamics, tunable pharmacokinetics that can be adapted for blood pool, liver, kidney, and lymphatic imaging, the ability to be a drug carrier, and flexibility for labeling due to their inherent multivalency. Clinical applications are increasingly being developed, particularly in lymphatic imaging. Herein we present a broad overview of dendrimer-based MRI contrast agents with attention to the unique chemistry and physical properties as well as emerging clinical applications.
淋巴结早期微型转移酶的MR和光学成像:具有纳米尺寸剂的三重标记,产生不同的信号。
DOI: 10.1002/cmmi.489
发表时间: 2012-03
影响因子: --
作者:
Kosaka N;Bernardo M;Mitsunaga M;Choyke PL;Kobayashi H
通讯作者: Kobayashi H
DOI: 10.1016/j.toxlet.2013.02.009
发表时间: 2013-05-10
期刊: TOXICOLOGY LETTERS
影响因子: 3.5
作者:
Cancino, J.;Paino, I. M. M.;Zucolotto, V.
通讯作者: Zucolotto, V.
DOI: 10.1021/nn3038995
发表时间: 2013-01-01
期刊: ACS NANO
影响因子: 17.1
作者:
Choi, Seok Ki;Myc, Andrzej;Baker, James R., Jr.
通讯作者: Baker, James R., Jr.
基于物理和生物学的下一代分子成像探针的合理化学设计:混合方式,颜色和信号。
DOI: 10.1039/c1cs15077d
发表时间: 2011-09
影响因子: 46.2
作者:
Kobayashi H;Longmire MR;Ogawa M;Choyke PL
通讯作者: Choyke PL
DOI: 10.1111/j.1523-1755.2004.00532.x
发表时间: 2004-04-01
影响因子: 19.6
作者:
Kobayashi, H;Kawamoto, S;Star, RA
通讯作者: Star, RA